Dr. Reddy's Laboratories Ltd. (RDY)
12.12
-0.06
(-0.45%)
USD |
NYSE |
Aug 31, 10:14
Dr. Reddy's Laboratories Price to Book Value : 2.493 for Aug. 31, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.505 |
| August 27, 2026 | 2.501 |
| August 26, 2026 | 2.513 |
| August 25, 2026 | 2.538 |
| August 24, 2026 | 2.513 |
| August 21, 2026 | 2.505 |
| August 20, 2026 | 2.490 |
| August 19, 2026 | 2.490 |
| August 18, 2026 | 2.499 |
| August 17, 2026 | 2.490 |
| August 14, 2026 | 2.523 |
| August 13, 2026 | 2.554 |
| August 12, 2026 | 2.548 |
| August 11, 2026 | 2.560 |
| August 10, 2026 | 2.499 |
| August 07, 2026 | 2.513 |
| August 06, 2026 | 2.490 |
| August 05, 2026 | 2.496 |
| August 04, 2026 | 2.488 |
| August 03, 2026 | 2.482 |
| July 31, 2026 | 2.437 |
| July 30, 2026 | 2.433 |
| July 29, 2026 | 2.418 |
| July 28, 2026 | 2.412 |
| July 27, 2026 | 2.420 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.424 |
| July 23, 2026 | 2.427 |
| July 22, 2026 | 2.340 |
| July 21, 2026 | 2.583 |
| July 20, 2026 | 2.577 |
| July 17, 2026 | 2.591 |
| July 16, 2026 | 2.612 |
| July 15, 2026 | 2.626 |
| July 14, 2026 | 2.640 |
| July 13, 2026 | 2.657 |
| July 10, 2026 | 2.712 |
| July 09, 2026 | 2.856 |
| July 08, 2026 | 2.904 |
| July 07, 2026 | 3.009 |
| July 06, 2026 | 2.953 |
| July 02, 2026 | 2.957 |
| July 01, 2026 | 2.877 |
| June 30, 2026 | 2.980 |
| June 29, 2026 | |
| June 26, 2026 | |
| June 25, 2026 | |
| June 24, 2026 | |
| June 23, 2026 | |
| June 22, 2026 | |
| June 18, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 5.384 |
| Takeda Pharmaceutical Co., Ltd. | 1.223 |
| Novo Nordisk A/S | 5.912 |
| Perrigo Co. Plc | 0.7994 |
| Innoviva, Inc. | 1.237 |
Price to Book Value Related Metrics
| PE Ratio | 27.25 |
| PS Ratio | 2.762 |
| Price to Free Cash Flow | 132.89 |
| Price | 12.12 |
| Earnings Yield | 3.67% |
| Market Cap | 10.10B |
| Operating PE Ratio | 27.42 |